New Centers for Disease Control and Prevention data is showing that newly released RSV vaccines are highly effective at keeping infants from becoming hospitalized. The CDC says nirsevimab was 90% ...

Maternal respiratory syncytial virus (RSV) vaccination and infant nirsevimab immunization, administered alone or sequentially, are safe and effective, according to a study published online May 4 in ...

Maternal respiratory syncytial virus prefusion F (RSVpreF) vaccination was associated with a substantial reduction in the risk for hospital admissions for RSV-related lower respiratory tract ...

It has been a brutal viral season, but as RSV cases surged in New York, Northwell Health doctors say infant hospitalizations remained down. They credit a fairly new vaccine for that. It is ...

ATLANTA -- Maternal respiratory syncytial virus (RSV) vaccination during pregnancy and infant RSV immunization -- either alone or combined -- appeared to be safe and effective at boosting neutralizing ...

Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized with severe lung infections, found a new study published in The Lancet Child ...

FARGO — Pediatricians at Sanford Health say a recently developed method of protecting babies from RSV showed incredible results. Dr. Stephanie Hanson said last season was the first time a “monoclonal ...

Nirsevimab significantly reduced respiratory syncytial virus (RSV)–associated hospitalizations in infants during the 2024-2025 season, consistent with previous findings. The study used a large dataset ...